在“Elsevier电子期刊”中,命中:29条,耗时:小于0.01 秒

在所有数据库中总计命中:295

1.Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
作者: ; nter Emonsa ; emons@med.uni-goettingen.de" class="auth_mail" title="E-mail the corresponding author ; Christian Kurzederb ; c.kurzeder@kliniken-essen-mitte.de" class="auth_mail" title="E-mail the corresponding author ; Barbara Schmalfeldtc ; 1 ; b.schmalfeldt@uke.de" class="auth_mail" title="E-mail the corresponding author ; Petra Neuserd ; Petra.Neuser@KKS.uni-marburg.de" class="auth_mail" title="E-mail the corresponding author ; Nikolaus de Gregorioe ; Nikolaus.deGregorio@uniklinik-ulm.de" class="auth_mail" title="E-mail the corresponding author ; Jacobus Pfistererf ; 2 ; jacobus.pfisterer@googlemail.com" class="auth_mail" title="E-mail the corresponding author ; Tjoung-Won Park-Simong ; park-simon.tjoung-won@mh-hannover.de" class="auth_mail" title="E-mail the corresponding author ; Sven Mahnerh ; 3 ; Sven.Mahner@med.uni-muenchen.de" class="auth_mail" title="E-mail the corresponding author ; Willibald Schrö ; deri ; prof.schroeder@gynaekologicum-bremen.de" class="auth_mail" title="E-mail the corresponding author ; Hans-Joachim Lü ; ckj ; hlueck@goph.de" class="auth_mail" title="E-mail the corresponding author ; Martin Leonhard Heubnerk ; martin.heubner@uk-essen.de" class="auth_mail" title="E-mail the corresponding author ; Lars Hankerl ; 4 ; Lars.Hanker@uksh.de" class="auth_mail" title="E-mail the corresponding author ; Falk Thielm ; 5 ; Falk.Thiel@af-k.de" class="auth_mail" title="E-mail the corresponding author ; Felix Hilpertn ; felix.hilpert@gmail.com" class="auth_mail" title="E-mail the corresponding author
刊名:Gynecologic Oncology
出版年:2016
2.The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function
刊名:American Journal of Kidney Diseases
出版年:2016
5.Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
作者:Prof Andreas du Bois ; MDa ; prof.dubois@googlemail.com" class="auth_mail" title="E-mail the corresponding author ; Prof Gunnar Kristensen ; PhDb ; Prof Isabelle Ray-Coquard ; MDc ; Alexander Reuss ; MScd ; Sandro Pignata ; MDe ; Prof Nicoletta Colombo ; MDf ; g ; Ursula Denison ; MDh ; Prof Ignace Vergote ; MDi ; Jose M del Campo ; MDj ; Petronella Ottevanger ; PhDk ; Martin Heubner ; MDl ; Thomas Minarik ; PhDm ; Emmanuel Sevin ; MDn ; Nikolaus de Gregorio ; MDo ; Prof Mariusz Bidziński ; MDp ; Prof Jacobus Pfisterer ; MDq ; Susanne Malander ; MDr ; Prof Felix Hilpert ; MDs ; Mansoor R Mirza ; MDt ; Prof Giovanni Scambia ; MDu ; Prof Werner Meier ; MDv ; Maria O Nicoletto ; MDw ; Prof Line Bjø ; rge ; PhDx ; Alain Lortholary ; MDy ; Martin Oliver Sailer ; PhDz ; Michael Merger ; MDz ; Philipp Harter ; MDa ; on behalf of the AGO Study Group led Gynecologic Cancer Intergroup (GCIG)/European Network of Gynaecologic Oncology Trials Groups (ENGOT) Intergroup Consortium
刊名:The Lancet Oncology
出版年:2016
1
2
3
按检索点细分(29)
题名(5)
作者(19)
关键词(7)
文摘(7)
按出版年细分(29)
2016年(5)
2015年(1)
2013年(5)
2012年(3)
2011年(1)
2010年(1)
2009年(2)
2008年(1)
2007年(1)
2006年(4)
2005年(2)
2000年及以前(3)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.